ArticleFrontiers in immunology2025
High tumor CD161 expression predicts a survival advantage and marks a Th1-skewed microenvironment.
Briana Amicarella Burns et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it